Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stachys lavandulifolia vs medroxyprogesterone for symptomatic treatment of polycystic ovarian syndrome
IRCT138903013922N1Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- May 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of medroxyprogesterone acetate in polycystic ovary syndrome (PCOS) and menstrual disorders (2 arms), sponsored by Kermanshah University of Medical Sciences. Started May 2010; status: completed.
02
Drugs
medroxyprogesterone acetate
03
Conditions
polycystic ovary syndrome (PCOS)menstrual disorders
Beyond the preview
Go deeper on IRCT138903013922N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138903013922N1.